Concentra Group Holdings Parent, Inc. (CON)
NYSE: CON · Real-Time Price · USD
20.03
+0.47 (2.40%)
Dec 20, 2024, 4:02 PM EST - Market closed

Company Description

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States.

The company offers occupational and consumer health services, including workers’ compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics.

It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces.

The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.

Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent logo
Country United States
Founded 1979
IPO Date Jul 25, 2024
Industry Medical Care Facilities
Sector Healthcare
Employees 9,020
CEO William Newton

Contact Details

Address:
4714 Gettysburg Road, PO Box 2034
Mechanicsburg, Pennsylvania 17055
United States
Phone 717 972 1100
Website concentra.com

Stock Details

Ticker Symbol CON
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
IPO Price $23.50
CIK Code 0002014596
ISIN Number US20603L1026
Employer ID 30-1006613
SIC Code 8093

Key Executives

Name Position
William Keith Newton Chief Executive Officer and Director
Matthew T. DiCanio M.B.A., MBA President and Chief Financial Officer
Su Zan Nelson CPA, CPA Executive Vice President and Chief Accounting Officer
John A. deLorimier Executive Vice President and Chief Information and Technology Officer
Giovanni Gallara Executive Vice President and Chief Clinical Services Officer
Timothy F. Ryan Executive Vice President and Chief Legal Counsel
Thomas A. Devasia Executive Vice President and Chief Marketing and Innovation Officer
Danielle Kendall Executive Vice President and Chief People Officer
Dr. John R. Anderson DO, FACOEM Executive Vice President and Chief Medical Officer
Michael A. Kosuth Executive Vice President and Chief Operating Officer of East

Latest SEC Filings

Date Type Title
Dec 9, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Dec 6, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Dec 3, 2024 SC 13D General statement of acquisition of beneficial ownership
Dec 3, 2024 SC 13D General statement of acquisition of beneficial ownership
Nov 29, 2024 8-K Current Report
Nov 27, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 26, 2024 8-K Current Report
Nov 12, 2024 8-K Current Report
Nov 6, 2024 10-Q Quarterly Report
Oct 31, 2024 8-K Current Report